285 related articles for article (PubMed ID: 34537329)
1. Alternative platelet activation pathways and their role in neurodegenerative diseases.
Ferrer-Raventós P; Beyer K
Neurobiol Dis; 2021 Nov; 159():105512. PubMed ID: 34537329
[TBL] [Abstract][Full Text] [Related]
2. Impact of Amyloid-β on Platelet Mitochondrial Function and Platelet-Mediated Amyloid Aggregation in Alzheimer's Disease.
Donner L; Feige T; Freiburg C; Toska LM; Reichert AS; Chatterjee M; Elvers M
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502546
[TBL] [Abstract][Full Text] [Related]
3. Blood platelets in the progression of Alzheimer's disease.
Gowert NS; Donner L; Chatterjee M; Eisele YS; Towhid ST; Münzer P; Walker B; Ogorek I; Borst O; Grandoch M; Schaller M; Fischer JW; Gawaz M; Weggen S; Lang F; Jucker M; Elvers M
PLoS One; 2014; 9(2):e90523. PubMed ID: 24587388
[TBL] [Abstract][Full Text] [Related]
4. Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides.
Di Scala C; Yahi N; Flores A; Boutemeur S; Kourdougli N; Chahinian H; Fantini J
Biochim Biophys Acta; 2016 Feb; 1862(2):213-22. PubMed ID: 26655601
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases.
Devi L; Anandatheerthavarada HK
Biochim Biophys Acta; 2010 Jan; 1802(1):11-9. PubMed ID: 19619643
[TBL] [Abstract][Full Text] [Related]
6. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
7. β-Amyloid promotes platelet activation and activated platelets act as bridge between risk factors and Alzheimer's disease.
Li TR; Liu FQ
Mech Ageing Dev; 2022 Oct; 207():111725. PubMed ID: 35995275
[TBL] [Abstract][Full Text] [Related]
8. Platelet-generated amyloid beta peptides in Alzheimer's disease and glaucoma.
Inyushin M; Zayas-Santiago A; Rojas L; Kucheryavykh Y; Kucheryavykh L
Histol Histopathol; 2019 Aug; 34(8):843-856. PubMed ID: 30945258
[TBL] [Abstract][Full Text] [Related]
9. Glycation in Parkinson's disease and Alzheimer's disease.
Vicente Miranda H; El-Agnaf OM; Outeiro TF
Mov Disord; 2016 Jun; 31(6):782-90. PubMed ID: 26946341
[TBL] [Abstract][Full Text] [Related]
10. Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases.
Tabner BJ; Turnbull S; El-Agnaf O; Allsop D
Curr Top Med Chem; 2001 Dec; 1(6):507-17. PubMed ID: 11895127
[TBL] [Abstract][Full Text] [Related]
11. Beta amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: usage of a novel blood brain barrier endothelial cell model system.
Davies TA; Long HJ; Eisenhauer PB; Hastey R; Cribbs DH; Fine RE; Simons ER
Amyloid; 2000 Sep; 7(3):153-65. PubMed ID: 11019856
[TBL] [Abstract][Full Text] [Related]
12. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.
Masliah E; Rockenstein E; Veinbergs I; Sagara Y; Mallory M; Hashimoto M; Mucke L
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12245-50. PubMed ID: 11572944
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial degradation of amyloidogenic proteins - A new perspective for neurodegenerative diseases.
Lautenschäger J; Kaminski Schierle GS
Prog Neurobiol; 2019 Oct; 181():101660. PubMed ID: 31301323
[TBL] [Abstract][Full Text] [Related]
14. Amyloid β-peptide-dependent activation of human platelets: essential role for Ca2+ and ADP in aggregation and thrombus formation.
Canobbio I; Guidetti GF; Oliviero B; Manganaro D; Vara D; Torti M; Pula G
Biochem J; 2014 Sep; 462(3):513-23. PubMed ID: 24984073
[TBL] [Abstract][Full Text] [Related]
15. Amyloids on Membrane Interfaces: Implications for Neurodegeneration.
Mahakud AK; Shaikh J; Rifa Iqbal VV; Gupta A; Tiwari A; Saleem M
J Membr Biol; 2022 Dec; 255(6):705-722. PubMed ID: 35670831
[TBL] [Abstract][Full Text] [Related]
16. Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets.
Kokjohn TA; Van Vickle GD; Maarouf CL; Kalback WM; Hunter JM; Daugs ID; Luehrs DC; Lopez J; Brune D; Sue LI; Beach TG; Castaño EM; Roher AE
Biochim Biophys Acta; 2011 Nov; 1812(11):1508-14. PubMed ID: 21784149
[TBL] [Abstract][Full Text] [Related]
17. Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer's and Parkinson's Disease.
Vella LJ; Hill AF; Cheng L
Int J Mol Sci; 2016 Feb; 17(2):173. PubMed ID: 26861304
[TBL] [Abstract][Full Text] [Related]
18. Current Views on the Role of Stress in the Pathogenesis of Chronic Neurodegenerative Diseases.
Khaspekov LG
Biochemistry (Mosc); 2021 Jun; 86(6):737-745. PubMed ID: 34225596
[TBL] [Abstract][Full Text] [Related]
19. Platelets: Their Potential Contribution to the Generation of Beta-amyloid Plaques in Alzheimer's Disease.
Humpel C
Curr Neurovasc Res; 2017; 14(3):290-298. PubMed ID: 28677497
[TBL] [Abstract][Full Text] [Related]
20. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
Williams SM; Schulz P; Sierks MR
Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
